Temporospatial Expression of Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases in Mouse Antigen-induced Arthritis

Overview

Journal Histochem Cell Biol

Publisher Springer

Specialties Biochemistry
Cell Biology

Date 2005 Sep 1

PMID 16133125

Citations 5

Authors

Kirsi Joronen

Veli-Matti Kahari

Eero Vuorio

Affiliations

Soon will be listed here.

Abstract

Several lines of evidence speak for an important role of matrix metalloproteinases (MMPs) in the development of progressive joint destruction. To better understand the role of MMPs and their tissue inhibitors (TIMPs) in this process, we have used the antigen-induced arthritis model to study the temporospatial expression of several MMPs and TIMPs during the progression of arthritis. Arthritis was induced by a single intra-articular injection of methylated bovine serum albumin (mBSA) into one or both knee joints of adult mice previously immunised against mBSA. Samples were collected at 3, 7, 21 and 42 days after induction of arthritis for histology and RNA extraction, and analysed by Northern hybridisation, histochemistry and immunohistochemistry for production of several MMPs and TIMPs -1, -2 and -3. A systematic analysis of MMP and TIMP mRNA levels in mouse knee joints demonstrated a general upregulation of both MMPs and TIMPs during progression of arthritis. Upregulation of MMP-9, -13 and -14 coincided with the advancement of cartilage degeneration, but the expression patterns of MMP-9 and -13 also followed the course of synovial inflammation. TIMPs were steadily upregulated throughout the examination period. Immunohistochemical localisation of MMPs and TIMPs suggested the synovium to be the major source of MMP and TIMP production in arthritis, although articular cartilage chondrocytes also showed an increased production of both MMPs and TIMPs.

Citing Articles

RNA Extraction from Cartilage: Issues, Methods, Tips.

Pagani S, Maglio M, Sicuro L, Fini M, Giavaresi G, Brogini S Int J Mol Sci. 2023; 24(3).

PMID: 36768444 PMC: 9917073. DOI: 10.3390/ijms24032120.

Interferon-gamma inhibits interleukin-1beta-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis.

Page C, Smale S, Carty S, Amos N, Lauder S, Goodfellow R Arthritis Res Ther. 2010; 12(2):R49.

PMID: 20307272 PMC: 2888198. DOI: 10.1186/ar2960.

Osteochondral angiogenesis and increased protease inhibitor expression in OA.

Franses R, McWilliams D, Mapp P, Walsh D Osteoarthritis Cartilage. 2010; 18(4):563-71.

PMID: 20060952 PMC: 2877870. DOI: 10.1016/j.joca.2009.11.015.

The histochemistry and cell biology vade mecum: a review of 2005-2006.

Taatjes D, Zuber C, Roth J Histochem Cell Biol. 2006; 126(6):743-88.

PMID: 17149649 DOI: 10.1007/s00418-006-0253-7.

Recent progress in histochemistry and cell biology: the state of the art 2005.

Taatjes D, Roth J Histochem Cell Biol. 2005; 124(6):547-74.

PMID: 16283358 DOI: 10.1007/s00418-005-0110-0.

References

Hegemann N, Wondimu A, Ullrich K, Schmidt M . Synovial MMP-3 and TIMP-1 levels and their correlation with cytokine expression in canine rheumatoid arthritis. Vet Immunol Immunopathol. 2003; 91(3-4):199-204. DOI: 10.1016/s0165-2427(03)00005-9. View

Amour A, Slocombe P, Webster A, Butler M, Knight C, Smith B . TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 1998; 435(1):39-44. DOI: 10.1016/s0014-5793(98)01031-x. View

Marini S, Fasciglione G, Monteleone G, Maiotti M, Tarantino U, Coletta M . A correlation between knee cartilage degradation observed by arthroscopy and synovial proteinases activities. Clin Biochem. 2003; 36(4):295-304. DOI: 10.1016/s0009-9120(03)00029-8. View

Ahonen M, Baker A, Kahari V . Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res. 1998; 58(11):2310-5. View

Podworny N, Kandel R, Renlund R, Grynpas M . Partial chondroprotective effect of zoledronate in a rabbit model of inflammatory arthritis. J Rheumatol. 1999; 26(9):1972-82. View

Johansson N, Kahari V . Matrix metalloproteinases in squamous cell carcinoma. Histol Histopathol. 2000; 15(1):225-37. DOI: 10.14670/HH-15.225. View

Iannone F, Lapadula G . The pathophysiology of osteoarthritis. Aging Clin Exp Res. 2004; 15(5):364-72. DOI: 10.1007/BF03327357. View

Baker A, Zaltsman A, George S, Newby A . Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest. 1998; 101(6):1478-87. PMC: 508704. DOI: 10.1172/JCI1584. View

Kevorkian L, Young D, Darrah C, Donell S, Shepstone L, Porter S . Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum. 2004; 50(1):131-41. DOI: 10.1002/art.11433. View

10.

Cunnane G, FitzGerald O, Hummel K, Youssef P, Gay R, Gay S . Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritis. Arthritis Rheum. 2001; 44(8):1744-53. DOI: 10.1002/1529-0131(200108)44:8<1744::AID-ART309>3.0.CO;2-K. View

11.

Vu T, Shipley J, Bergers G, Berger J, Helms J, Hanahan D . MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 1998; 93(3):411-22. PMC: 2839071. DOI: 10.1016/s0092-8674(00)81169-1. View

12.

Somerville R, Oblander S, Apte S . Matrix metalloproteinases: old dogs with new tricks. Genome Biol. 2003; 4(6):216. PMC: 193609. DOI: 10.1186/gb-2003-4-6-216. View

13.

Close D . Matrix metalloproteinase inhibitors in rheumatic diseases. Ann Rheum Dis. 2002; 60 Suppl 3:iii62-7. PMC: 1766680. DOI: 10.1136/ard.60.90003.iii62. View

14.

Jackson C, Nguyen M, Arkell J, Sambrook P . Selective matrix metalloproteinase (MMP) inhibition in rheumatoid arthritis--targetting gelatinase A activation. Inflamm Res. 2001; 50(4):183-6. DOI: 10.1007/s000110050743. View

15.

van Meurs J, van Lent P, Holthuysen A, Lambrou D, Bayne E, Singer I . Active matrix metalloproteinases are present in cartilage during immune complex-mediated arthritis: a pivotal role for stromelysin-1 in cartilage destruction. J Immunol. 1999; 163(10):5633-9. View

16.

Brown P . Ongoing trials with matrix metalloproteinase inhibitors. Expert Opin Investig Drugs. 2000; 9(9):2167-77. DOI: 10.1517/13543784.9.9.2167. View

17.

Vihinen P, Kahari V . Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer. 2002; 99(2):157-66. DOI: 10.1002/ijc.10329. View

18.

Neuhold L, Killar L, Zhao W, Sung M, Warner L, Kulik J . Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest. 2001; 107(1):35-44. PMC: 198546. DOI: 10.1172/JCI10564. View

19.

Levi E, Fridman R, Miao H, Ma Y, Yayon A, Vlodavsky I . Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc Natl Acad Sci U S A. 1996; 93(14):7069-74. PMC: 38937. DOI: 10.1073/pnas.93.14.7069. View

20.

Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov S . MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell. 1999; 99(1):81-92. DOI: 10.1016/s0092-8674(00)80064-1. View